These findings suggest that REDD1 downregulation promotes tumor progression by stimulating mTORC1-mediated tumor cell proliferation15 or by increasing the levels of mitochondrial ROS as a regulator of HIF-1-dependent tumorigenic metabolism17. This evidence concerns the gene DDIT4 and neoplasm.